Methyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 5g

2-(Naphthalen-2-yloxy)benzonitrile, 95+%, 100mg

(S)-5-(8,9,10,11,12,13,14,15-Octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-5H-dibenzo[b,f]azepine, 98%, 5g

2-Hydrazino-3-methylpyridine, 95.0%, 1g

6-chloro-9-methyl-9H-purin-2-amine, 95.0%, 250mg

(5-Bromo-2-methylthiazol-4-yl)methanol, 95%, 1g

2-(Benzo[d]thiazol-2-ylthio)succinic acid, 95.0%, 50g

Antibody Diluent clear, 500 ml, 4 x 125 ml

4-Hydroxy-3-methoxy-alpha-methylbenzyl Alcohol>98.0%(GC)1g

(4-(Cyclohexyloxy)phenyl)boronic acid, 98%, 250mg

3,3-Difluoroazetidine hydrochloride, 98.0%, 1g

(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (S)-2-acetamido-3-phenylpropanoate, 98%, 25g

2-(Ethyl(m-tolyl)amino)ethanol, 95.0%, 1kg